No Detail Found!

Malignant Hyperthermia: Survival without Dantrolene - a Case Report.

Author(s)
Humaira Jadoon Department of Anesthesiology & Pain Management, KRL General Hospital, Islamabad, Pakistan
TariqH Khan Department of Anesthesiology & Pain Management, KRL General Hospital, Islamabad, Pakistan
Fida Ahmed Department of Anesthesiology & Pain Management, KRL General Hospital, Islamabad, Pakistan
Shahida Tasneem Department of Anesthesiology & Pain Management, KRL General Hospital, Islamabad, Pakistan
Abstract
We encountered a case of malignant hyperthermia in a 52 year old male undergoing open reduction/internal fixation of humerus fracture under general anesthesia. Isoflurane has been reported as a potent triggering agent of malignant hyperthermia. Dantrolene remains the gold standard for treating this life threatening syndrome but it is not available in many countries including Pakistan. However, we successfully managed our patient by timely recognition of this syndrome and administering prompt and effective symptomatic treatment.
Publication Details
Page(s) 236-239
DOI DOI not available
Published Journal: Anaesthesia, Pain and Intensive Care, Volume: 20, Issue: 2, Year: 2016

Request the full text from PASTIC

References
Anesthesiology, 1994., 80 771 -9
RosenbergH,BrandomBW,SambuughinN.,BarashPG,CullenBF,StoeltingRK,CahalanMK,StockMC, .Malignant hyperthermia and other inherited disorders,Clinical Anesthesia. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2009 -
McGuireN,EasyWR,KlinglerW,RueffertH,Lehmann-HornF,GirardT,HopkinsPM, .Core myopathies and risk of malignant hyperthermia,Anaesthesia 45 124 -127
AnesthAnalg, 2009., 109 1167 -73
.,doi:10 -
ZhaoF,LiP,ChenSR,LouisCF,FruenBR, 2009.Dantrolene inhibition of ryanodine receptor Ca2+ release channels: Molecular mechanism and isoform selectivity,J Biol Chem. 10 1049 -53
RosenbergH,FletcherJE, 2001.An update on the malignant hyperthermia syndrome, 276 13810 -6
NasirKK,ZafarAB,MansoorF,MushtaqS,AhmadJ,KhanIM, .Malignant hyperthermia,J Coll Phys Surg Pak 23 84 -97
2006.Clinical presentation, treatment and complications of malignant hyperthermia in North America from, -
AnesthAnalg, 2010., 110 498 -507
BoschX,PochE,GrauJM, ., 10 -
2009.Rhabdomyolysis and acute kidney injury,N Engl J Med 361 62 -72
StudoRT,CunhaLB,CarmoPL,MatosAR,TrachezMM,CardosoLA,NelsonP,LitmanRS, 2010.Malignant hyperthermia in children: an analysis of the North American malignant hyperthermia registry,Anesth Analg. 12 549 -56
2014., 10 369 -74
0

Citations

0

Downloads

77

Views